10A NCAC 41A .0101: Proposed Permanent Amendment

The proposed rule amends the communicable diseases and conditions reporting requirements to: (1) add Acute Flaccid Myelitis, Babesiosis, Varicella, and Interferon Gamma Release Assay testing; (2) re-list Zika; and (3) make technical changes related to nomenclature, timing of reporting, and scientific progress in laboratory testing and reporting. In addition, the text in italics adding a reporting requirement for novel coronavirus was adopted by CPH under emergency procedures on February 5, 2020 and effective on February 17, 2020, as well as proposed under temporary procedures.

UPDATE, 03/26/20: In an abundance of caution and to address protective measures to help prevent the spread of COVID-19, the NC Commission for Public Health is providing notice of a change of procedure for the public hearing on the proposed permanent amendment of 10A NCAC 41A .0101. The public hearing will still be conducted on the same date and at the same time as previously published in the North Carolina Register, but will be held by teleconference, instead of being held in person, as follows:

Date: Monday, April 13, 2020
Time: 10:00 a.m.
Teleconference Phone Number: 919-662-4658 (no access code needed)

Proposed Rule:	10A NCAC 41A .0101
Notice:	03/02/2020 Memo: Notification of Proposed Permanent Amendment of 10A NCAC 41A .0101
Fiscal Note:	10A NCAC 41A .0101 Reportable Diseases and Conditions
Federal Certification:	N/A

Public Comments

The public comment period was from March 2, 2020 - May 1, 2020.

Additional Links

Procedure for Subjecting a Proposed Rule to Legislative Review